Compare DSP Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.01
2.09
NAV
₹49.35
₹47.68
Fund Started
12 Nov 2018
25 Jun 2018
Fund Size
₹3514.02 Cr
₹6624.58 Cr
Exit Load
Exit load of 0.50% if redeemed within 1 month.
Exit load of 1% if redeemed within 15 days.
1 Year
10.33%
8.10%
3 Year
20.99%
24.57%
5 Year
14.73%
15.96%
Equity
92.30%
96.05%
Cash
7.70%
3.95%
Top 10 Holdings
Cipla Ltd. | 8.35% |
Ipca Laboratories Ltd. | 8.21% |
Sun Pharmaceutical Industries Ltd. | 8.14% |
Illumina Inc. (USA) | 7.59% |
Sai Life Sciences Ltd. | 6.88% |
Gland Pharma Ltd. | 6.54% |
Globus Medical Inc | 5.72% |
Apollo Hospitals Enterprise Ltd. | 4.81% |
Cohance Lifesciences Ltd. | 4.13% |
Vijaya Diagnostic Centre Ltd. | 3.60% |
Sun Pharmaceutical Industries Ltd. | 12.20% |
Dr. Reddy's Laboratories Ltd. | 8.22% |
Mankind Pharma Ltd. | 6.98% |
Cipla Ltd. | 6.67% |
Alkem Laboratories Ltd. | 5.67% |
Divi's Laboratories Ltd. | 5.57% |
Cohance Lifesciences Ltd. | 4.31% |
Medplus Health Services Ltd. | 3.66% |
Max Healthcare Institute Ltd. | 3.10% |
Syngene International Ltd. | 2.89% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
12 Nov 2018
25 Jun 2018
